Vivian Aranez, MD
Allergy & Immunology · Huntington Beach, CANPI 1699032805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Grifols USA, LLC at 25.2% of the total.
Across 207 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$1K
- GSK$829
- Sanofi$511
- Alk-abello, Inc$473
- Regeneron Healthcare Solutions, Inc.$461
- Takeda Pharmaceuticals U.S.A., Inc.$367
- plus $2K from 17 others
What the payments were for
- Consulting fees$160%
- Speaking & faculty fees$1753%
- Food & beverage$5,51897%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 61 | $1,441 |
| GSK | 26 | $829 |
| Sanofi | 16 | $511 |
| Alk-abello, Inc | 15 | $473 |
| Regeneron Healthcare Solutions, Inc. | 14 | $461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $367 |
| AstraZeneca | 13 | $330 |
| Genentech USA, Inc. | 5 | $230 |
| Aimmune Therapeutics, Inc. | 2 | $195 |
| Phadia US Inc. | 5 | $156 |
| Amgen | 1 | $111 |
| Novartis | 5 | $111 |
| Pfizer | 4 | $106 |
| Covis Pharma GmbH | 4 | $84 |
| Optinose US, Inc. | 5 | $81 |
| Kaleo, Inc. | 3 | $58 |
| Biocryst US Sales Co., LLC | 1 | $37 |
| Ventec Life Systems, Inc. | 1 | $26 |
| Advanced Respiratory, Inc | 1 | $26 |
| CSL Behring | 1 | $25 |
| Sobi, Inc | 1 | $22 |
| Shire North American Group Inc | 1 | $16 |
| ADMA Biomanufacturing LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,708 in reported general payments places this provider in the 65th percentile of 426 allergy & immunology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 126 | $4,587 |
| BreynaBudesonide/Formoterol Fumarate | 13 | $3,330 |
| Ipratropium Bromide | 27 | $873 |
| Montelukast Sodium | 48 | $608 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $591 |
| Fluticasone Propionate | 11 | $187 |
| Azithromycin | 20 | $93 |
| Levocetirizine Dihydrochloride | 13 | $72 |
| Prednisone | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Huntington Beach
- Steven WeinsteinHuntington Beach$239K
- Raffi TachdjianSanta Monica$3.7M
- Bob GengSan Diego$3.3M
- Vinay MehtaLaguna Niguel$1.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Brian Modenala Jolla$453K
- Heena Shah PatelUpland$428K
- Jacob OffenbergerGranada Hills$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.